Torre-Bouscoulet L, Aburto-Valencia O, García-Sancho FC, Fernández-Plata R, Martínez-Briseño D, Franco-Marina F, Pérez-Padilla R

Language: Spanish
References: 20
Page: 10-19
PDF size: 115.96 Kb.

ABSTRACT

Background: The life-threatening asthma is the most serious clinical expression of asthma, even though the risk factors associated with its occurrence have been incompletely characterized. Objective: To determine the association of life-threatening asthma with environmental, occupational and patients exposures obtained from a standardized questionnaire in a national referral hospital for respiratory diseases. Material and methods: We performed a case-control study (hospital-based) at the National Institute of Respiratory Diseases Ismael Cosio Villegas for the period 2004-2009. Cases were patients with life-threatening asthma defined as: patients with acute asthma who came from the intensive care or intubation died, or did hypercapnia. antiretroviral crisis was defined as: a) hypercapnia (PaCO2 › 6.65 KPa (50 mm/Hg) and/or acidosis with pH ‹ 7.30; b) cardiac arrest; c) the need for intubation and ventilator management, d) stay in a unit intensive care unit, e)death. The diagnosis of acute asthma was accepted if it was described in the file of each patient. We randomly selected two control groups: Group 1 patients otolaryngology, but without lung disease and control. Group 2 patients with non life-threatening asthma. Cases and controls were matched for age and sex. The protocol was approved by the Committee on Science and Bioethics National Institute of Respiratory Diseases (approval number C17-08). Results: We compared 50 patients with life-threatening asthma with 48 controls with non life-threatening asthma and 96 otolaryngology controls. In multivariate analysis, patients with life-threatening asthma, in comparison with otolaryngology controls showed higher consumption of tobacco (OR = 3.4 [95% CI 1.1-11.2], p = 0.04); alcohol (OR = 6.0, [95% CI 1.5-24.4], p = 0.01); have carpet in the bedroom (OR = 15.2 [95% CI 2.6-89], p = 0.003) and to have birds at home (OR = 3.1 [95% CI 1.1-9.1], p = 0.03) after control for the presence of cats and indoor air pollution. When comparing patients with and without fatal asthma and otolaryngology controls we found no significant differences in the risk factors analyzed. Regarding the entry treatment, only 53% of asthma cases with RV were treated with inhaled steroid. Six of 60 patients with ARV (10%) could be successfully treated with noninvasive ventilation. Conclusions: The ARV patients showed a higher frequency of risk factors such as exposure to smoking, alcohol, pets and carpets compared to controls ORL. When comparing patients with and without asthma risk vital, this study found no association between exposure to environmental factors and an increased risk of developing fatal asthma. Only 53% of patients were ARV treatment with inhaled steroids, reflecting the low utilization the same in patients with severe asthma and in our series, 10% of patients were successfully treated with NIV.

REFERENCES

1. Plaza V, Rodrigo GJ. Asma aguda. Barcelona: Ergon 2007:107-113.

2. Marquette CH, Saulnier F, Leroy O, et al. Long-term prognosis of near-fatal asthma. A 6 years follow-up study of 145 asthmatic patients who underwent mechanical for a near-fatal attack of asthma. Am Rev Respir Dis 1992;146:76-81.

3. Plaza V, Serrano J, Picado C, et al. Frecuency and clinical characteristics of rapid-onset fatal and near-fatal asthma. Eur Respir J 2002;19:846-852.

4. Rea HH, Scragg R, Jackson R, Beaglehole R, Fenwick J, Sutherland DC. A case-control study of deaths from asthma. Thorax 1986;41:833-839.

5. The Global Initiative for Asthma (GINA). Updated December 2011. Access date: July 09, 2012. Available from: http://ginasthma.org.

6. Pérez-Padilla R, Pérez-Guzmán C, Báez-Saldaña R, Torres-Cruz A. Cooking with biomass stoves and tuberculosis: a case control study. Int J Tuberc Lung Dis 2001;5:441-447.

7. Jaakkola JJ, Ieromnimon A, Jaakkola MS. Interior surface materials and asthma in adults: a population-based incident case-control study. Am J Epidemiol 2006;164:742-749.

8. Carrard A, Pichler C. House dust mite allergy. Ther Umsch 2012;69:249-252.

9. Chen YC, Tsai CH, Lee YL. Early-life indoor environmental exposures increase the risk of childhood asthma. Int J Hyg Environ Health 2011;215: 19-25.

10. Ayres JG. Alcohol-induced bronchial asthma. J Allergy Clin Immunol 1997;6:860.

11. Jang AS, Park JS, Lee JH, et al. The impact of smoking on clinical and therapeutic effects in asthmatics. J Korean Med Sci 2009;24:209-214.

12. Tse LA, Yu IT, Wang XR, Qiu H, Au JS. Synergistic effect between alcohol consumption and familial susceptibility on lung cancer risk among Chinese men. PLoS One 2012;7:40647.

13. Rao VG, Gopi PG, Bhat J, Yadav R, Selvakumar N, Wares DF. Selected risk factors associated with pulmonary tuberculosis among Saharia tribe of Madhya Pradesh, central India. Eur J Public Health 2012;22:271-273.

14. Ladefoged K, Rendal T, Skifte T, Andresson M, Søborg B, Koch A. Risk factors for tuberculosis in Greenland: case-control study. Int J Tuberc Lung Dis 2011;15:44-49.

15. Gorman J, Cook A, Ferguson C, van Buynder P, Fenwick S, Weinstein P. Pet birds and risks of respiratory disease in Australia: a review. Aus N Z J Public Health 2009;33:167-172.

16. Jenkins C, Costello J, Hodge L. Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice. BMJ 2004;328:434.

17. Yoshimine F, Hasegawa T, Suzuki E, et al. Contribution of aspirin-intolerant asthma to near fatal asthma based on a questionnaire survey in Niigata Prefecture, Japan. Respirology 2005;10:477-484.

18. Matsuse H, Shimoda T, Matsuo N, et al. Aspirin-induced asthma as a risk factor for asthma mortality. J Asthma 1997;34:413-417.

19. Morell F, Genover T, Muñoz X, García-Aymerich J, Ferrer J, Cruz MJ. Rate and characteristics of asthma exacerbations: the ASMAB I study. Arch Bronconeumol 2008;44:303-311.

20. Rodríguez-Trigo G, Plaza V, Picado C, Sanchis J. Management according to the Global Initiative for Asthma guidelines of patients with near-fatal asthma reduces morbidity and mortality. Arch Bronconeumol 2008;44:192-196.